POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer (POSNOC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02401685

Recruitment Status : Active, not recruiting

First Posted : March 30, 2015

Last Update Posted : September 16, 2021

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborators:

University of Nottingham

Sussex Health Outcomes Research & Education in Cancer (SHORE-C)

NCRI Radiotherapy Trials QA Group (RTTQA)

Breast Cancer Trials, Australia and New Zealand

Information provided by (Responsible Party):

Dr Amit Goyal, University Hospitals of Derby and Burton NHS Foundation Trust

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	July 2026
Estimated Study Completion Date :	December 31, 2026

Publications:

Goyal A, Dodwell D. POSNOC: A Randomised Trial Looking at Axillary Treatment in Women with One or Two Sentinel Nodes with Macrometastases. Clin Oncol (R Coll Radiol). 2015 Dec;27(12):692-5. doi: 10.1016/j.clon.2015.07.005. Epub 2015 Aug 5. No abstract available.

Dodwell D, Goyal A. Axillary conservation in early breast cancer. Br J Surg. 2015 Oct;102(11):1297-9. doi: 10.1002/bjs.9881. Epub 2015 Jul 7. No abstract available.

Goyal A, Dodwell D, Reed MW, Coleman RE. Axillary treatment in women with one or two sentinel nodes with macrometastases: more evidence is needed to inform practice. J Clin Oncol. 2014 Dec 1;32(34):3902. doi: 10.1200/JCO.2014.57.3717. Epub 2014 Sep 22. No abstract available.

To Top